Muscular Dystrophy Ireland is to receive a grant of $30,000 after winning an award for its role in improving the lives of individuals affected by the condition. Muscular dystrophy is a group of diseases that cause progressive weakness and loss of muscle mass. In muscular dystrophy, abnormal genes, or mutations, interfere with the production of proteins needed to form healthy muscle. Muscular Dystrophy Ireland will receive a Strategies to Realise Innovation, Vision and Empowerment (STRIVE) Award, which were created by PTC Therapeutics to aid charities committed to serving the duchenne muscular dystrophy (DMD) community. Muscular Dystrophy Ireland was one of eight organisations to receive the award, with judges commending the “innovative and collaborative” nature of the winning applications.

Source: The Irish Times September 08, 2018 11:03 UTC